Risk assessment of carcinogenesis at implantation sites

Area of Science:

• Oncology
• Biomaterials Science
• Pathology

Background:

• Foreign-body reactions to implants are a known phenomenon.
• Cancer development at the site of implants (foreign-body carcinogenesis) is a rare but documented complication.
• Long-term data on implant-associated cancer incidence is crucial for patient safety and device regulation.

Purpose of the Study:

• To evaluate the incidence of cancer at implantation sites based on literature review and case studies.
• To assess the potential for precancerous cell identification in chronic foreign-body reactions.
• To predict the long-term cancer risk associated with medical implants.

Main Methods:

• Literature review of 98 reported foreign-body or scar-related cancers.
• Analysis of implant duration in relation to cancer development.
• Histopathological examination of 27 explanted specimens with chronic foreign-body reactions.
• Application of a cell-culture technique to detect precancer cells in human tissues.

Main Results:

• Over 25% of reported cancers occurred within 15 years, and over 50% within 25 years post-implantation.
• Despite many implants being in place for 10-20 years, the observed cancer incidence is lower than expected.
• No precancer cells were detected in human chronic foreign-body reaction tissues using the employed cell-culture technique.

Conclusions:

• The incidence of cancers at implantation sites is predicted to remain low.
• Human responses to foreign bodies differ significantly from those in mice, where foreign-body tumors are more common.
• Current evidence suggests a low risk of developing cancer due to the presence of medical implants.